About this trial
The ITACA study is a prospective, observational no profit registry enrolling patients with Acute Coronary Syndrome and angiographic evidence of coronary aneurysms and/or ectasia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Signature of informed consent;
Patients aged ≥18 years;
diagnosis of ACS (ST-elevation myocardial infarction, non ST-elevation myocardial infarction, unstable angina), in accordance with the definition provided in the latest guidelines;
diagnosis of ectasia or coronary aneurysm according to the definitions contained in this protocol, either in the culprit vessel of the SCA than in another vessel. Coronary pseudoaneurysms are excluded.
Disqualifiers
impossibility or unwillingness to provide signed informed consent;
contraindications to dual antiplatelet therapy;
contraindications to anticoagulant therapy;
active bleeding or severe anemia (Hb <6 g / dl);
Trial population
patients undergoing coronary angiography with diagnosis of ACS and contextual detection of coronary ectasia or aneurysm in accordance with the definitions specified below. Patients with coronary pseudoaneurysms are excluded.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Major adverse cardiac events
A composite endpoint of myocardial infarction, stroke, cardiovascular death, myocardial revascularization and hospitalisation due to cardiovascular events
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Federico II University
Lead sponsor
Fondazione GISE Onlus
Collaborator